Why the study?
Are ACE InDel and AGT rs699 polymorphisms associated with genetic susceptibility to type 2 diabetes mellitus?
Are ACE InDel and AGT rs699 polymorphisms associated with genetic susceptibility to type 2 diabetes mellitus?
The AGT rs699 polymorphism, but not the ACE InDel polymorphism, is associated with genetic susceptibility to type 2 diabetes mellitus in a Southern Brazilian population.
Supports AGT rs699 as DM2 susceptibility marker; hypothesis-generating and should not yet change practice.
The aim of the current study was to investigate the association between the InDel polymorphism in the angiotensin I-converting enzyme gene (ACE) and the rs699 polymorphism in the angiotensinogen gene (AGT) and diabetes mellitus type 2 (DM2) in a sample population from Southern Brazil. A case-control study was conducted with 228 patients with DM2 and 183 controls without DM2. The ACE InDel polymorphism was genotyped by polymerase chain reaction (PCR) with specific primers, followed by electrophoresis on 1.5% agarose gel. The AGT rs699 polymorphism was genotyped using a real-time PCR assay. No significant association between the ACE InDel polymorphism and DM2 was detected (P = 0.97). However, regarding the AGT rs699 polymorphism, DM2 patients had a significantly higher frequency of the AG genotype and lower frequency of the GG genotype when compared to the controls (P = 0.03). Our results suggest that there is an association between the AGT rs699 polymorphism and DM2 in a Brazilian sample.
No takes yet. Share an insight, caveat, or question.
Wollinger et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: